Savella Kit
Product Images NDC 0456-1500

8 FDA label images from Allergan, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Savella (NDC 0456-1500). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula Is Milnacipran Hydrochloride Is A Selective Norepinephrine And Serotonin Reuptake Inhibitor; It Inhibits Norepinephrine Uptake With Greater Potency Than Serotonin. It Is A Racemic Mixture With The Chemical Name: (±)-[1r(s),2s(r)]-2-(aminomethyl)-n,n-diethyl-1-phenylcyclopropanecarboxamide Hydrochloride. (Savella 01)

The Structural Formula Is Milnacipran Hydrochloride Is A Selective Norepinephrine And Serotonin Reuptake Inhibitor; It Inhibits Norepinephrine Uptake With Greater Potency Than Serotonin. It Is A Racemic Mixture With The Chemical Name: (±)-[1r(s),2s(r)]-2-(aminomethyl)-n,n-diethyl-1-phenylcyclopropanecarboxamide Hydrochloride. (Savella 01)
Chemical structure of milnacipran hydrochloride, the active ingredient in Savella. The diagram shows the molecular framework including a cyclopropane ring and phenyl group, depicting the compound's arrangement with hydrochloride.*
FDA Label Image

Figure 1: Patients Achieving Various Levels Of Pain Relief With Concurrent Ratings Of Being Much Or Very Much Improved On The Pgic ― Study 1 (Savella 02)

Figure 1:	Patients Achieving Various Levels Of Pain Relief With Concurrent Ratings Of Being Much Or Very Much Improved On The Pgic ― Study 1 (Savella 02)
A line chart depicting the percent of patients improved against percent improvement in pain from baseline. The chart includes three curves labeled Plcb, MLN 100mg, and MLN 200mg, with the x-axis showing percent improvement in pain and the y-axis showing percent of patients improved.*
FDA Label Image

Figure 2 : Patients Achieving Various Levels Of Pain Relief With Concurrent Ratings Of Being Much Or Very Much Improved On The Pgic ― Study 2 (Savella 03)

Figure 2	:	Patients Achieving Various Levels Of Pain Relief With Concurrent Ratings Of Being Much Or Very Much Improved On The Pgic ― Study 2 (Savella 03)
A line graph depicting the percent of patients improved versus percent improvement in pain from baseline for Savella (milnacipran hydrochloride) at 100 mg and 200 mg doses compared to placebo. The graph uses different lines to represent placebo, 100 mg milnacipran, and 200 mg milnacipran groups.*
FDA Label Image

Principal Display Panelrx Onlyndc 0456-1512-60savella®(milnacipran Hci) Tablets12.5 mg60 Tabletsdispense The Accompanyingmedication Guide To Each Patient.abbvie (Savella 04)

Principal Display Panelrx Onlyndc 0456-1512-60savella®(milnacipran Hci) Tablets12.5 mg60 Tabletsdispense The Accompanyingmedication Guide To Each Patient.abbvie (Savella 04)
Savella 12.5 mg film-coated tablets label for oral use containing milnacipran hydrochloride. The label indicates a package of 60 tablets, manufactured by Allergan, Inc. It includes dosage information, storage instructions, a barcode, and the NDC number 0456-1512-60.*
FDA Label Image

Principal Display Panelrx Onlyndc 0456-1525-60savella®(milnacipran Hci) Tablets25 mg60 Tabletsdispense The Accompanyingmedication Guide To Each Patient.abbvie (Savella 05)

Principal Display Panelrx Onlyndc 0456-1525-60savella®(milnacipran Hci) Tablets25 mg60 Tabletsdispense The Accompanyingmedication Guide To Each Patient.abbvie (Savella 05)
Savella 12.5 mg tablets packaging label for film-coated oral tablets containing milnacipran HCl. The label includes storage instructions, quantity of 100 tablets per bottle, and manufacturer Allergan, Inc. The NDC number and branding appear clearly on the label.*
FDA Label Image

Principal Display Panelrx Only Ndc 0456-1550-60savella®(milnacipran Hci) Tablets50 mg60 Tabletsdispense The Accompanying Medicationguide To Each Patient.abbvie (Savella 06)

Principal Display Panelrx Only   Ndc 0456-1550-60savella®(milnacipran Hci) Tablets50 mg60 Tabletsdispense The Accompanying Medicationguide To Each Patient.abbvie (Savella 06)
Savella 25 mg film-coated tablets packaging label by Allergan, Inc. The label shows the proprietary name Savella with the generic name milnacipran HCl underneath. The package contains 60 tablets with a strength of 25 mg each. The label includes instructions to dispense the accompanying medication guide and storage information, as well as a barcode and NDC 0456-1525-60.*
FDA Label Image

Principal Display Panelrx Onlyndc 0456-1510-60savella®(milnacipran Hci) Tablets100 mg60 Tabletsdispense The Accompanying Medicationguide To Each Patient.abbvie (Savella 07)

Principal Display Panelrx Onlyndc 0456-1510-60savella®(milnacipran Hci) Tablets100 mg60 Tabletsdispense The Accompanying Medicationguide To Each Patient.abbvie (Savella 07)
Savella 50 mg film-coated tablets packaging label displaying the product name, active ingredient milnacipran hydrochloride, and that the bottle contains 60 tablets. It includes dosing instructions to dispense with the Medication Guide, storage temperature guidelines, and cautions to keep out of reach of children. The labeler is Allergan, Inc. The NDC number 0456-1550-60 is shown along with a barcode and a copyright date of 2016.*
FDA Label Image

Principal Display Panelndc 0456-1500-55savella®(milnacipran Hci) Tablets4-week Titration Packthis 4-week Titration Pack Of Savellaincludes The Following:• Five 12.5 mg Tablets• Eight 25 mg Tablets• Forty-two 50 mg Tabletsdispense The Enclosed Medication Guide To Each Patient.for Additional Information, Visit Www.savella.comrx Onlyabbvie (Savella 08)

Principal Display Panelndc 0456-1500-55savella®(milnacipran Hci) Tablets4-week Titration Packthis 4-week Titration Pack Of Savellaincludes The Following:•	Five 12.5 mg Tablets•	Eight 25 mg Tablets•	Forty-two 50 mg Tabletsdispense The Enclosed Medication Guide To Each Patient.for Additional Information, Visit Www.savella.comrx Onlyabbvie (Savella 08)
Savella 100 mg film-coated tablets label for oral use, containing milnacipran hydrochloride. The label indicates the package contains 60 tablets and is produced by Allergan, Inc. It includes storage instructions and a note to dispense an accompanying Medication Guide to each patient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.